• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.73% Nasdaq Up1.46%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NGM
    12.39 Up 0.14(1.14%) 3:11PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Net Income (34,759) (9,696) (27,901) (18,109)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,054  412  570  1,355  
    Adjustments To Net Income5,307  6,232  4,976  6,278  
    Changes In Accounts Receivables(935)(1,975)5,314  5,547  
    Changes In Liabilities(7,573)(28,613)79,645  (25,809)
    Changes In Inventories -   -   -   -  
    Changes In Other Operating Activities1,500  1,736  (1,370)(1,914)
    Total Cash Flow From Operating Activities (35,079) (31,685) 61,097   (32,833)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,204)(1,321)(1,731)(1,545)
    Investments25,163  (35,773)(38,834)42,131  
    Other Cash flows from Investing Activities -  (2) -   -  
    Total Cash Flows From Investing Activities 23,959   (37,096) (40,565) 40,586  
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -  (7) -  
    Sale Purchase of Stock4,265  3,803  1,645  2,802  
    Net Borrowings -  344  400  300  
    Other Cash Flows from Financing Activities -  (1)2  (1)
    Total Cash Flows From Financing Activities 4,265   4,146   2,040   3,101  
    Effect Of Exchange Rate Changes -   -   -   -  
    Change In Cash and Cash Equivalents (6,855) (64,635) 22,572   10,854  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.